Literature DB >> 26084137

Surgical management of pulmonary aspergilloma: clinical experience with 77 cases.

Koray Aydoğdu, Funda İncekara, Mehmet Furkan Şahin, Selim Şakir Erkmen Gülhan, Göktürk Findik, İrfan Taştepe, Sadi Kaya.   

Abstract

BACKGROUND/AIM: This retrospective study evaluated the clinical presentation, underlying lung disease, surgical indications, technique, treatment outcomes, and postoperative complications of pulmonary aspergilloma.
MATERIALS AND METHODS: We evaluated 77 patients who underwent pulmonary resection of an aspergilloma at Atatürk Chest Diseases and Thoracic Surgery Research and Training Hospital between January 2000 and December 2013. The initial operations were 4 pneumonectomies, 24 lobectomies, 9 lobectomy plus myoplasties, 10 segmental resections, and 30 wedge resections. Six reoperations were carried out to deal with postoperative complications: 1 myoplasty, 2 completion lobectomies plus myoplasties, 2 myoplasties with rib resections, and 1 completion lobectomy.
RESULTS: The subjects comprised 53 males (mean age: 44.26 (range: 10-73) years) and 24 females (mean age: 48.25 (range: 26-70) years). The most common indication for surgery was hemoptysis in 52 patients (67.53%). The most common underlying lung disease was tuberculosis in 37 patients (48.05%). Forty patients (51.94%) had a simple pulmonary aspergilloma and 37 (48.05%) had a complex pulmonary aspergilloma. Major complications occurred in 18 patients (23.37%). The postoperative mortality rate was 3.89%, with 3 patients dying.
CONCLUSION: Surgical resection of pulmonary aspergilloma is the best way to prevent recurrent hemoptysis with low morbidity and mortality.

Entities:  

Mesh:

Year:  2015        PMID: 26084137     DOI: 10.3906/sag-1401-165

Source DB:  PubMed          Journal:  Turk J Med Sci        ISSN: 1300-0144            Impact factor:   0.973


  8 in total

1.  Video-assisted thoracoscopic surgery for invasive pulmonary fungal infection in haematology patients.

Authors:  Han Ma; Jun Wang; Xiao Ma; Shiying Zheng; Haitao Ma; Jinfeng Ge
Journal:  J Thorac Dis       Date:  2019-07       Impact factor: 2.895

2.  Risk factors of severe hemoptysis in patients with fungus ball.

Authors:  Tae Hoon Kim; Hyun Jung Koo; Chae-Man Lim; Sang-Bum Hong; Jin Won Huh; Kyung Wook Jo; Tae Sun Shim; Woo Sung Kim; Younsuck Koh
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

3.  Lung resection in pulmonary aspergilloma: experience of a Moroccan center.

Authors:  Mohammed Massine El Hammoumi; Omar Slaoui; Fayçal El Oueriachi; El Hassane Kabiri
Journal:  BMC Surg       Date:  2015-10-16       Impact factor: 2.102

4.  Hemoptysis from complex pulmonary aspergilloma treated by cavernostomy and thoracoplasty.

Authors:  Nguyen Truong Giang; Le Tien Dung; Nguyen Thanh Hien; Truong Thanh Thiet; Phan Sy Hiep; Nguyen The Vu; Dinh Cong Pho; Nguyen Van Nam; Pham Ngoc Hung
Journal:  BMC Surg       Date:  2019-12-05       Impact factor: 2.102

5.  Plombage for Hemoptysis Control in Pulmonary Aspergilloma: Safety and Effectiveness of Forgettable Surgery in High-Risk Patients.

Authors:  Nguyen Truong Giang; Le Tien Dung; Nguyen Thanh Hien; Truong Thanh Thiet; Phan Sy Hiep; Dinh Cong Pho; Pham Ngoc Hung
Journal:  Ann Thorac Cardiovasc Surg       Date:  2021-01-06       Impact factor: 1.520

6.  Factors affecting survival after anatomical lung resection in pulmonary aspergilloma: Our 10-year single institution experience.

Authors:  Celal Buğra Sezen; Cemal Aker; Mustafa Vedat Doğru; Yunus Aksoy; Salih Bilen; Yaşar Sönmezoğlu; Volkan Erdoğu; Levent Cansever; Muzaffer Metin
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2022-01-28       Impact factor: 0.332

7.  Is there any change in disease presentation and surgical outcomes in patients with pulmonary aspergilloma? An evaluation of the time trend.

Authors:  Atilla Pekçolaklar; Necati Çıtak; Yunus Aksoy; Volkan Erdoğu; Muzaffer Metin
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2022-04-27       Impact factor: 0.704

8.  Intervention treatment on massive hemoptysis of pulmonary aspergilloma.

Authors:  Guanghui He; Wenyu Liu; Zhiqiang Gao; Zhi Gao; Hongsheng Gao; Yanjie Wang
Journal:  Exp Ther Med       Date:  2017-03-15       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.